Notícias Profound Medical Corporation - PROF | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Profound Medical Corporation (PROF)
Profound Medical Corporation (PROF) Notícias

Profound Medical Corporation (PROF)

7,55

0,03

(0,40%)

Fechado 24 Novembro 6:00PM

Atrasado por 15 minutos

7,58

0,03

(0,40%)

Após o horário de negociação: 9:59PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form 144 - Report of proposed sale of securities

Profound Medical to Participate in the Stifel 2024 Healthcare Conference

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical Announces Third Quarter 2024 Financial Results

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA

Form S-8 - Securities to be offered to employees in employee benefit plans

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Profound Medical

K3 Business Technology

Armac Locacao Logistica ... ON

DJ US Hotels Total Stock...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições